Linking Syndromic testing and AMS

Professor Manaf Alqahtani elaborates on AMS in this video, discussing the value syndromic testing — and diagnostic stewardship using syndromic testing — adds to existing AMS programs.

As Professor Alqahtani explains in the video, rapid molecular identification methods — such as syndromic testing — shorten the time taken to identify offending microorganisms. This can result in targeted antimicrobial therapy being given sooner for the appropriate duration, and can subsequently aid antimicrobial stewardship by encouraging efficient use of antimicrobials.

Organism Identification and Initiation of Targeted Antimicrobial Therapy: Traditional versus Rapid Molecular diagnostics for bloodstream infection – click here for a closer look

For more information and further reading on this topic, please see the see also section below.